JCIC Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

JCIC Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$995	Buy	+2	New	+$1.08K	﹤0.01%	143

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JCIC Asset Management's TMO Position: Q1 2025 in Review

JCIC Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2025: 2 shares worth $995. The stake represents ﹤0.01% of the portfolio and ranks #143 among its holdings.

2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

JCIC Asset Management held 2 shares of Thermo Fisher Scientific worth $995 as of Q1 2025.
Thermo Fisher Scientific was a new JCIC Asset Management position in Q1 2025.
Thermo Fisher Scientific made up ﹤0.01% of JCIC Asset Management's portfolio in Q1 2025, its #143 holding.
2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on JCIC Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.